The therapy of basic fibroblast growth factor (bFGF) for perianal abscess and postoperative surgical site infection

The therapy of basic fibroblast growth factor (bFGF) for perianal abscess and postoperative surgical site infection - The therapy of bFGF

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000036007

Enrollment

Registered

2019-03-01

Start date

2018-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perianal abscess and Surgical site infection

Interventions

We spray the wound with bFGF by 5 times.We performed the treatment 2 times everyday.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The children with perianal absecess and SSI

Exclusion criteria

Exclusion criteria: When suffer severe adverse event on children

Design outcomes

Primary

Measure	Time frame
wound healing	—

Countries

Japan

Contacts

Public ContactYuhki Arai

Niigata University Dental and Medical Hospital Pediatric Surgery

arai@med.niigata-u.ac.jp025-227-2258

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026